CN104366491A - Water lily lozenge for blood pressure reduction - Google Patents
Water lily lozenge for blood pressure reduction Download PDFInfo
- Publication number
- CN104366491A CN104366491A CN201310357232.8A CN201310357232A CN104366491A CN 104366491 A CN104366491 A CN 104366491A CN 201310357232 A CN201310357232 A CN 201310357232A CN 104366491 A CN104366491 A CN 104366491A
- Authority
- CN
- China
- Prior art keywords
- blood pressure
- lozenge
- water
- pressure reduction
- water lily
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007937 lozenge Substances 0.000 title claims abstract description 14
- 241000209490 Nymphaea Species 0.000 title claims abstract description 12
- 235000016791 Nymphaea odorata subsp odorata Nutrition 0.000 title claims abstract description 12
- 230000036772 blood pressure Effects 0.000 title abstract description 14
- 230000009467 reduction Effects 0.000 title abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 16
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 16
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 15
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 8
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 8
- 229960002675 xylitol Drugs 0.000 claims abstract description 8
- 235000010447 xylitol Nutrition 0.000 claims abstract description 8
- 239000000811 xylitol Substances 0.000 claims abstract description 8
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 5
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 5
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 240000002853 Nelumbo nucifera Species 0.000 claims description 20
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 20
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 20
- 240000005250 Chrysanthemum indicum Species 0.000 claims description 19
- 235000018959 Chrysanthemum indicum Nutrition 0.000 claims description 18
- 244000179560 Prunella vulgaris Species 0.000 claims description 15
- 235000008113 selfheal Nutrition 0.000 claims description 15
- 239000012141 concentrate Substances 0.000 claims description 14
- 235000014571 nuts Nutrition 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 238000007598 dipping method Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 239000003826 tablet Substances 0.000 claims description 8
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 6
- 238000005469 granulation Methods 0.000 claims description 5
- 230000003179 granulation Effects 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000000314 lubricant Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000007779 soft material Substances 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 206010020772 Hypertension Diseases 0.000 abstract description 15
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 10
- 239000011707 mineral Substances 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 241000411851 herbal medicine Species 0.000 abstract description 4
- 229930006000 Sucrose Natural products 0.000 abstract description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract description 3
- 239000005720 sucrose Substances 0.000 abstract description 3
- 208000004930 Fatty Liver Diseases 0.000 abstract description 2
- 206010019708 Hepatic steatosis Diseases 0.000 abstract description 2
- 229960004106 citric acid Drugs 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 208000010706 fatty liver disease Diseases 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 abstract description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract 1
- 230000010757 Reduction Activity Effects 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 229940057948 magnesium stearate Drugs 0.000 abstract 1
- 235000010755 mineral Nutrition 0.000 description 9
- 208000002173 dizziness Diseases 0.000 description 7
- 235000013619 trace mineral Nutrition 0.000 description 7
- 239000011573 trace mineral Substances 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000036541 health Effects 0.000 description 5
- WUYQEGNOQLRQAQ-CQSZACIVSA-N (+)-pronuciferine Chemical compound C([C@H]1N(C)CCC=2C=C(C(=C3C=21)OC)OC)C13C=CC(=O)C=C1 WUYQEGNOQLRQAQ-CQSZACIVSA-N 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 230000036770 blood supply Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000001631 hypertensive effect Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- WUYQEGNOQLRQAQ-UHFFFAOYSA-N (+)-pronuciferine Natural products C1=2C3=C(OC)C(OC)=CC=2CCN(C)C1CC13C=CC(=O)C=C1 WUYQEGNOQLRQAQ-UHFFFAOYSA-N 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000002366 mineral element Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229930001545 pronuciferine Natural products 0.000 description 2
- WZRCQWQRFZITDX-UHFFFAOYSA-N (RS)-norcoclaurine Chemical compound C1=CC(O)=CC=C1CC1C2=CC(O)=C(O)C=C2CCN1 WZRCQWQRFZITDX-UHFFFAOYSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000131317 Capitulum Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010012373 Depressed level of consciousness Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- AJPXZTKPPINUKN-UHFFFAOYSA-N Isoliensinin Natural products C1=CC(OC)=CC=C1CC1C2=CC(OC=3C(=CC=C(CC4C5=CC(O)=C(OC)C=C5CCN4C)C=3)O)=C(OC)C=C2CCN1C AJPXZTKPPINUKN-UHFFFAOYSA-N 0.000 description 1
- AJPXZTKPPINUKN-FIRIVFDPSA-N Isoliensinine Chemical compound C1=CC(OC)=CC=C1C[C@@H]1C2=CC(OC=3C(=CC=C(C[C@@H]4C5=CC(O)=C(OC)C=C5CCN4C)C=3)O)=C(OC)C=C2CCN1C AJPXZTKPPINUKN-FIRIVFDPSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- XCUCMLUTCAKSOZ-JSOSNVBQSA-N Liensinine Natural products C([C@@H]1C=2C=C(C(=CC=2CCN1C)OC)OC=1C(O)=CC=C(C=1)C[C@@H]1N(C)CCC=2C=C(C(=CC=21)OC)OC)C1=CC=C(O)C=C1 XCUCMLUTCAKSOZ-JSOSNVBQSA-N 0.000 description 1
- XCUCMLUTCAKSOZ-FIRIVFDPSA-N Liensinine Chemical compound C([C@@H]1C=2C=C(C(=CC=2CCN1C)OC)OC=1C(O)=CC=C(C=1)C[C@H]1N(C)CCC=2C=C(C(=CC=21)OC)OC)C1=CC=C(O)C=C1 XCUCMLUTCAKSOZ-FIRIVFDPSA-N 0.000 description 1
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- MIBATSHDJRIUJK-UHFFFAOYSA-N Neferine Natural products C1=CC(OC)=CC=C1CC1C2=CC(OC=3C(=CC=C(CC4C5=CC(OC)=C(OC)C=C5CCN4C)C=3)O)=C(OC)C=C2CCN1C MIBATSHDJRIUJK-UHFFFAOYSA-N 0.000 description 1
- MIBATSHDJRIUJK-ROJLCIKYSA-N Neferine Chemical compound C1=CC(OC)=CC=C1C[C@@H]1C2=CC(OC=3C(=CC=C(C[C@@H]4C5=CC(OC)=C(OC)C=C5CCN4C)C=3)O)=C(OC)C=C2CCN1C MIBATSHDJRIUJK-ROJLCIKYSA-N 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- WZRCQWQRFZITDX-AWEZNQCLSA-N Norcoclaurine Natural products C1=CC(O)=CC=C1C[C@H]1C2=CC(O)=C(O)C=C2CCN1 WZRCQWQRFZITDX-AWEZNQCLSA-N 0.000 description 1
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000020682 bottled natural mineral water Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- PEFNSGRTCBGNAN-QNDFHXLGSA-N luteolin 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-QNDFHXLGSA-N 0.000 description 1
- KBGKQZVCLWKUDQ-UHFFFAOYSA-N luteolin-glucoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC2=C1C(=O)C=C(C=1C=C(O)C(O)=CC=1)O2 KBGKQZVCLWKUDQ-UHFFFAOYSA-N 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000000492 nasalseptum Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 210000001202 rhombencephalon Anatomy 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a water lily lozenge for blood pressure reduction. Raw materials used in the invention mainly comprise water lily flower, water lily seed, wild chrysanthemum, Spica Prunellae, cassia seed, xylitol, maltodextrin, citric acid, magnesium stearate and Laoshan mineral water, and the lozenge is prepared through a special process. High blood pressure, high blood sugar and fatty liver are epidemic diseases at present. Blood pressure reduction drugs in the current market have the disadvantages of convenient administration and inconvenient carrying. The water lily lozenge for blood pressure reduction integrates the efficacies of a variety of Chinese herbal medicines with blood pressure reduction activity, is prepared from pure natural Chinese herbal medicines, has very good blood pressure reduction preventing and assisting effects, is simple to eat, and is convenient to carry. The lozenge adopting xylitol to substitute sucrose is suitable for more people, and is especially suitable for elevated blood pressure people to administrate.
Description
technical fieldthe present invention relates to a kind of water lily step-down lozenge, the raw material used is mainly oral shui solution, lotus nut, mother chrysanthemum, selfheal, cassia seed, xylitol, maltodextrin, citric acid, dolomol and Laoshan Spring Water.Through oral shui solution, lotus nut, mother chrysanthemum, selfheal, cassia seed → rinsing → pulverize → add water hot dipping carry → be incubated → coarse filtration → diatomite filter → vacuum concentration pan → concentrate → mix with other auxiliary materials → mixer granulation → drying → compressing tablet → sterilizing → packaging forms.
Hypertension, hyperglycaemia, fatty liver are present epidemic diseases, and reducing blood lipid, norcholesterol, hypotensively to have become when next hot issue.The hypertensive origin cause of formation is a lot.Antihypertensive drugs ubiquity commercially available at present eats, carry inconvenient shortcoming.The invention provides a kind of water lily step-down lozenge, integrate multiple effect having the Chinese herbal medicine of antihypertensive activity, pure natural Chinese herbal medicine is drawn materials, and has well prevention and secondary buck effect, edible simple, easy to carry.Instead of sucrose with xylitol in lozenge, applicable crowd is wider.The crowd that this lozenge is applicable to slight Hypertension takes.
background technologythe life of modern improves constantly, and causes nutrition unbalanced, and dietary structure is unreasonable; Both pursued and eaten smart, enjoy.Mouth is very popular, and health is influenced, and occurred three high three low symptoms, create hypertension, high fat of blood, hyperglycaemia, obese people constantly increases.Hypertensive harm is very serious.Hypertensive symptom varies with each individual.Early stage possibility is asymptomatic or symptom is not obvious, only after tired, stress, anxious state of mind, blood pressure can occur and raise, and recover normal after rest.Along with the course of disease extends, blood pressure significantly continues to raise, and there will be various symptom gradually.Dizzy and headache is the most common brain symptom of hypertension, and most of patients be the dull sense of discomfort of continuation, and frequent dizziness can hinder thinking, and reduction operating efficiency is absent minded, decrease of memory, especially goes down as very with recent memory power.Long-term hypertension causes cerebral blood supply insufficiency, is also to cause one of dizzy reason.The patient that some long-term blood pressure increases adapts to higher blood pressure, and when taking depressor and being down to normal by blood pressure, the inadaptable generation that also can regulate because of the cerebrovascular is dizzy.When blood pressure falls too low, sometimes also can feel dizzy, this is relevant with cerebral blood supply insufficiency.Headache can show as the pure pain of continuation or pulsation distending pain, even sometimes causes nausea, vomits, and how making caused by head vasoreflex strong contraction because blood pressure raises suddenly, the position of pain can at both sides temple or hindbrain.In addition because cranial nerve function is disorderly, agitation, palpitaition, insomnia, the symptom such as emotional can be there is; Whole body arteriolar spasm and limb muscle blood supply insufficiency, can cause extremity numbness, nape muscular tone, aches; The originally patient Yi Fasheng nosebleed of nasal septum position blood vessel existing defects.Therefore irritable prevention and therapy hypertension is very urgent.This water lily step-down lozenge provided by the invention, has gathered the antihypertensive effect of oral shui solution, lotus nut, mother chrysanthemum, selfheal, cassia seed, is the green health care food that a kind of applicable slight Hypertension crowd eats.
summary of the inventionmain points of the present invention are oral shui solution, lotus nut, mother chrysanthemum, selfheal, cassia seed → rinsing → pulverize → add water hot dipping to carry → be incubated → and coarse filtration → diatomite filter → vacuum concentration pan → concentrate → mix with other auxiliary materials → mixer granulation → drying → compressing tablet → sterilizing → packaging forms.
The material usage that the present invention selects following (component and percentage by weight % thereof): oral shui solution, lotus nut, mother chrysanthemum, selfheal, cassia seed (4:3:2:1:1) concentrate 10.0-20.0; Xylitol 50.0-70.0; Maltodextrin 10.0-15.0; Citric acid 1.0; Dolomol 0.4.
Oral shui solution: oral shui solution bitter but sweet flavor warm in nature, has promoting blood circulation and hemostasis, blood-activating analgetic, the wind clearing damp that disappears, the cool blood that clears away heart-fire, the puckery intestines of tonifying spleen, the effect such as promotes the production of body fluid to quench thirst.
Lotus nut: containing liensinine, isoliensinine, neferine, Nuciferine, Pronuciferine, lotusin, methyl-corypalline, demethyl coclaurine.Again containing flavonoids such as galuteolin, hyperin, rutins.Wherein Pronuciferine, Birdfoot, element, methyl-corypalline have band bitterness, and thus lotus nut is bitter, and ripe lotus nut can be bitter.Lotus nut is the dark green plumule of lotus seeds central authorities, bitter, has heat-clearing, controlling nocturnal emission with astringent drugs, calms the nerves, effect of cardiac stimulant.Drink after lotus nut 2 grams is soaked with boiling water, the diseases such as dysphoria that high fever causes, obnubilation and emission can be treated.Also hypertension, palpitaition and insomnia is used for the treatment of.
Mother chrysanthemum: mother chrysanthemum is the capitulum of composite family herbaceos perennial mother chrysanthemum, and profile is similar to chrysanthemum, wild by patana, field wing.With look yellow nothing stalk, complete, gas is fragrant, the non-standard-sized sheet person of flower is good.Mother chrysanthemum containing can be widely used in that treatment furunculosis carbuncle is swollen, abscess of throat, wind fire cute conjunctivitis, the disease such as dizzy of having a headache.There is again good hypotensive effect simultaneously, can be used for the supplemental treatment of high blood pressure.
Selfheal: clearing liver, dissipating bind, diuresis; Control the diseases such as seasonal febrile diseases, acute mastitis, order pain, jaundice, gonorrhoea, hypertension; Leaf can for tea.
Cassia seed: removing heat to brighten vision, relaxes bowel.For the puckery pain of hot eyes, the many tear of photophobia, have a headache dizzy, order is secretly failed to understand, constipation.Return liver, kidney, large intestine channel.There is effect of fat-reducing.Control wind-heat cute conjunctivitis, glaucoma, night blindness, hypertension, hepatitis, cirrhotic ascites, habitual constipation.
Laoshan Spring Water: the reasonable content containing the micro-index specified in the abundant macro-and trace-element useful to health, particularly mineral water standard, plays diseases prevention and health-care effect to human body especially.Measure through science, various chemical element in blood of human body, in micro-mean value and the earth's crust, elemental abundance is worth closely related, and mineral water is the mineral element in the dissolving earth's crust, so be rich in the necessary trace element of human body in mineral water.From modern age biochemistry, quantum chemistry and works pharmacological research prove, water mineral and trace element can not lack with healthy human life, can not replace completely with the mineral matter in food and trace element, mineral matter in water and trace element are ionic state, easily absorb by human body, it absorbs up to more than 90%, and absorption is fast.Mineral matter in food and trace element, due to the impact of string and phytic acid, absorptivity is most less than 30%, and what have is only less than 10%.So the natural mineral water drunk containing mineral matter and trace element is good for health.Also it is particularly worth mentioning that in addition: in water, pH value is also key factor to health, and human body fluid is alkalescent, and pH value range is 7.3 ~ 7.45.Mineral water belongs to alkalescent, and pH value, generally about 7.5, matches with the pH value of human body fluid, is conducive to maintaining normal osmotic pressure and acid-base balance, enhances metabolism.
Production technology of the present invention: oral shui solution, lotus nut, mother chrysanthemum, selfheal, cassia seed → rinsing → pulverize → add water hot dipping carry → be incubated → coarse filtration → diatomite filter → vacuum concentration pan → concentrate → → mixer granulation → drying → compressing tablet → sterilizing → packaging is mixed with other auxiliary materials.
The preparation method of product of the present invention is:
1) pretreatment: oral shui solution, lotus nut, mother chrysanthemum, selfheal, cassia seed are cleaned, shred, dried, and pulverizer is broken into fine powder;
2) hot dipping is extracted: raw material fine powder is put into jacketed pan, adds the Laoshan Spring Water of 30 times, hot water extraction's (90-100 degree) is also incubated 4 hours;
3) filter: first use 60 mesh filter screen coarse filtration, then carry out fine filtering through diatomite filter;
4) concentrated: filtrate is inputted vacuum concentration pan (vacuum 97kPa, temperature about 55), during by liquid concentration to former amount of water 1/20, become concentrate;
5) concentrate and other auxiliary materials are fully mixed by a certain percentage;
6) mix sufficient soft material to drop in swing granule and carry out causing grain, then particle is placed in vacuum drier carries out drying, vacuum degree control is at 0.053-0.060Mpa, and temperature controls to make the moisture of particle control be less than about 3% at 60-65 degree;
7), add lubricant (dolomol, 4 ‰) mixing in dried particles after, compressing tablet, irradiates 30 minutes under ultraviolet, then packs in time.
The present invention has the following advantages:
1) antihypertensive effect of oral shui solution, lotus nut, mother chrysanthemum, selfheal, cassia seed has been gathered, Be very effective;
2) edible simple, easy to carry;
3) Functionality, quality and appealing design, long-term eating has no side effect;
4) xylitol instead of sucrose, and applicable crowd is wider.
detailed description of the invention: below in conjunction with embodiment, the present invention is described in further detail:
For 100kg product of the present invention:
1. fill a prescription: (component and percentage by weight % thereof): oral shui solution, lotus nut, mother chrysanthemum, selfheal, cassia seed (4:3:2:1:1) concentrate 10.0-20.0; Xylitol 50.0-70.0; Maltodextrin 10.0-15.0; Citric acid 1.0; Dolomol 0.4.
2. production procedure: oral shui solution, lotus nut, mother chrysanthemum, selfheal, cassia seed → rinsing → pulverize → add water hot dipping carry → be incubated → coarse filtration → diatomite filter → vacuum concentration pan → concentrate → → mixer granulation → drying → compressing tablet → sterilizing → packaging is mixed with other auxiliary materials.
3. preparation method:
1) pretreatment: oral shui solution, lotus nut, mother chrysanthemum, selfheal, cassia seed are cleaned, shred, dried, and pulverizer is broken into fine powder;
2) hot dipping is extracted: raw material fine powder is put into jacketed pan, adds the Laoshan Spring Water of 30 times, hot water extraction's (90-100 degree) is also incubated 4 hours;
3) filter: first use 60 mesh filter screen coarse filtration, then carry out fine filtering through diatomite filter;
4) concentrated: filtrate is inputted vacuum concentration pan (vacuum 97kPa, temperature about 55), during by liquid concentration to former amount of water 1/20, become concentrate;
5) concentrate and other auxiliary materials are fully mixed by a certain percentage;
6) mix sufficient soft material to drop in swing granule and carry out causing grain, then particle is placed in vacuum drier carries out drying, vacuum degree control is at 0.053-0.060Mpa, and temperature controls to make the moisture of particle control be less than about 3% at 60-65 degree;
7), add lubricant (dolomol, 4 ‰) mixing in dried particles after, compressing tablet, irradiates 30 minutes under ultraviolet, then packs in time.
Claims (3)
1. the present invention relates to a kind of water lily step-down lozenge, it is characterized in that there is following formula (component and percentage by weight % thereof):
Oral shui solution, lotus nut, mother chrysanthemum, selfheal, cassia seed (4:3:2:1:1) concentrate 10.0-20.0; Xylitol 50.0-70.0; Maltodextrin 10.0-15.0; Citric acid 1.0; Dolomol 0.4.
2. an a kind of water lily step-down lozenge according to claim 1, is characterized in that having following production technology:
Oral shui solution, lotus nut, mother chrysanthemum, selfheal, cassia seed → rinsing → pulverize → add water hot dipping carry → be incubated → coarse filtration → diatomite filter → vacuum concentration pan → concentrate → → mixer granulation → drying → compressing tablet → sterilizing → packaging is mixed with other auxiliary materials.
3. an a kind of water lily step-down lozenge according to claim 1, is characterized in that having following preparation method:
1) pretreatment: oral shui solution, lotus nut, mother chrysanthemum, selfheal, cassia seed are cleaned, shred, dried, and pulverizer is broken into fine powder;
2) hot dipping is extracted: raw material fine powder is put into jacketed pan, adds the Laoshan Spring Water of 30 times, hot water extraction's (90-100 degree) is also incubated 4 hours;
3) filter: first use 60 mesh filter screen coarse filtration, then carry out fine filtering through diatomite filter;
4) concentrated: filtrate is inputted vacuum concentration pan (vacuum 97kPa, temperature about 55), during by liquid concentration to former amount of water 1/20, become concentrate;
5) concentrate and other auxiliary materials are fully mixed by a certain percentage;
6) mix sufficient soft material to drop in swing granule and carry out causing grain, then particle is placed in vacuum drier carries out drying, vacuum degree control is at 0.053-0.060Mpa, and temperature controls to make the moisture of particle control be less than about 3% at 60-65 degree;
7), add lubricant (dolomol, 4 ‰) mixing in dried particles after, compressing tablet, irradiates 30 minutes under ultraviolet, then packs in time.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310357232.8A CN104366491A (en) | 2013-08-16 | 2013-08-16 | Water lily lozenge for blood pressure reduction |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310357232.8A CN104366491A (en) | 2013-08-16 | 2013-08-16 | Water lily lozenge for blood pressure reduction |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104366491A true CN104366491A (en) | 2015-02-25 |
Family
ID=52545882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310357232.8A Pending CN104366491A (en) | 2013-08-16 | 2013-08-16 | Water lily lozenge for blood pressure reduction |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104366491A (en) |
-
2013
- 2013-08-16 CN CN201310357232.8A patent/CN104366491A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102302072B (en) | Alcohol alleviating and liver protecting healthcare tea, and preparation method thereof | |
CN1729874B (en) | Method for preparing composite powdered drink with mulberry leaf, mulberry and chrysanthemum flower | |
CN101756176A (en) | Anti-radiation eyesight protective health food and preparation method thereof | |
CN103961561A (en) | Dendrobe summer-heat relieving healthy product composition and preparation method thereof | |
CN103520621B (en) | A kind of Chinese medicine composition for the treatment of senile cataract and preparation method thereof | |
CN102551165A (en) | Four-season health beverage made from traditional Chinese medicines with effects of removing heat and relieving dryness and preparation method of same | |
CN106509261A (en) | Sugar-free herbal tea plant composition, and method for preparing drink and granule from composition | |
CN106578296A (en) | Formula of spina date seed tabletted candy and preparation method thereof | |
CN104431064A (en) | Blood glucose-lowering tea and preparation method thereof | |
CN101658227A (en) | Sugar-free health antipyretic tea and preparation method thereof | |
CN104323153A (en) | Health food with function of reducing hyperpiesia, hyperglycaemia and hyperlipemia | |
CN103749735A (en) | Instant sugar-free high GABA (Gamma Amino Acid Butyric Acid) folium mori uncongealed beancurd and preparation method thereof | |
CN103611039A (en) | Medicament for treating attention deficit hyperactivity disorder and preparation method thereof | |
CN105907458A (en) | Health-caring sesame oil suitable for people having hypertension, hyperglycemia and hyperlipidemia and preparation method of same | |
CN104273413A (en) | Wild chrysanthemum flower lozenges capable of lowering blood pressure | |
CN103550464A (en) | Particles for nourishing yin and blood and preparation method thereof | |
CN103463456B (en) | Traditional Chinese medicine composition and preparation method thereof | |
CN104365921A (en) | Manufacturing method of water lily instant blood pressure-reduction tea | |
CN104366491A (en) | Water lily lozenge for blood pressure reduction | |
CN103907721A (en) | Sleep promotion health care tea and its preparation method | |
CN102342514A (en) | Patrima villosa beverage and preparation method thereof | |
KR101072243B1 (en) | Preparation of liquefied Camellia tea | |
CN104366179A (en) | Manufacturing method of water lily stomach-strengthening lozenge | |
CN104365963A (en) | Manufacturing method of wild chrysanthemum flower blood pressure-reduction summer heat-relieving candy | |
CN104367969A (en) | Water lily capsule for stomach strengthening |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150225 |